Keith E. Stockerl-Goldstein, MD

Keith E. Stockerl-Goldstein is a Professor of Medicine in Division of Oncology, Section of Bone Marrow Transplant, Washington University School of Medicine. He is associated with Barnes-Jewish Hospital, St. Louis, Missouri.
Dr. Stockerl-Goldstein graduated (BA) in Biology from Washington University, Saint Louis, Missouri (1986) and did his MD from University of California Los Angeles (UCLA) School of Medicine, California 1991. He did his residency in internal medicine from Stanford University Hospital in 1993. He completed his fellowship in Bone Marrow

Transplantation (in 1995) and in Medical Oncology (in 1996) from Stanford University School of Medicine. He was also the Clinical Director of Adult Bone Marrow Transplantation Unit, Stanford University School of Medicine.
Dr. Keith E. Stockerl-Goldstein’s research interest lies in treatment of amyloidosis and hematologic malignancies such as multiple myeloma, leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma and myelodysplastic syndrome using chemotherapy, novel agents and stem-cell transplantation.
Representative Publications:

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Results of an Early Access Treatment Protocol of Daratumumab in United States Patients With Relapsed or Refractory Multiple Myeloma
Ibrutinib Alone or With Dexamethasone for Relapsed or Relapsed and Refractory Multiple Myeloma: Phase 2 Trial Results
Patterns of Infectious Complications in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Treated With 10-Day Decitabine RegimenTP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes